App-Quantinova.ai

Circulating tumor cells (CTC) but not circulating endothelial cells (CEC) are independent prognostic factors in neoadjuvant chemotherapy combined with bevacizumab in HER2 negative inflammatory breast cancer (IBC) in multicentre phase II trial BEVERLY1

Jean-Yves Pierga - American Association for Cancer Research (AACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

Bevacizumab

Predictive and pharmacodynamic biomarkers of the androgen receptor in circulating tumor cells

Jamie M. Sperger - American Association for Cancer Research (AACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

Androgen Tear

Non small cell lung cancer and circulating tumor cell: A different expression of EpCam and cytokeratins

Elisabetta Rossi - American Association for Cancer Research (AACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Non Small Cell Lung cancer

N/A

Longitudinal genetic characterization of circulating tumor cells in metastatic breast cancer patients

Valeria Sero - American Association for Cancer Research (AACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

Gemcitabine

The AdnaCellector, a new fully automated selection for circulating tumor cells in blood of primary and metastatic breast cancer patients

Maren Bredemeier - American Association for Cancer Research (AACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Expression of the autophagosomal marker LC3 on circulating tumor cells (CTCs) of patients with early and metastatic breast cancer (BC)

Maria Spiliotaki - American Association for Cancer Research (AACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

Tamoxifen

Bolus high-dose neoadjuvant sunitinib treatment overcomes potential for rebound growth during pre-surgical treatment breaks

Michalis Mastri - American Association for Cancer Research (AACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Renal cell carcinoma

Sunitinib

Extensive morphological heterogeneity of circulating and selected high metastatic variants and differential chemosensitivity of human prostate cancer in mouse models

Lei Zhang - American Association for Cancer Research (AACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

Cisplatin

Cancer associated macrophage-like cells as a blood-based biomarker for the screening of solid tumors

Daniel Adams - American Association for Cancer Research (AACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

N/A

Expression of metastasis-related miRNAs in EpCAM-positive CTC fraction in corresponding plasma and FFPEs of breast cancer patients with verified metastasis

Athina Markou - American Association for Cancer Research (AACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Immunostaining of MRP-1 protein in circulating tumor cells predicts shorter progression free survival in metastatic colorectal cancer patients

Emne A. Abdallah - American Association for Cancer Research (AACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

Adrucil injection

Aiming for Remission in Rheumatoid Arthritis: Clinical and Radiographic Outcomes from a Randomized Controlled Strategy Trial Investigating the Added Value of Ultrasonography in a Treat-to-Target Regimen

Espen A. Haavardsholm - American College of Rheumatology (ACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Neutropenia With Tocilizumab Treatment Is Not Associated With Increased Infection Risk In Patients With Systemic Juvenile Idiopathic Arthritis

Fabrizio De Benedetti - American College of Rheumatology (ACR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Tocilizumab

Trabecular BONE Score In Rheumatoid Arthritis and Ankylosing Spondylitis and Changes During LONG TERM Treatment With TNFA Blocking Agents

Eric Toussirot - American College of Rheumatology (ACR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ankylosing spondylitis

N/A

Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation For Relapsed/Refractory Hodgkin Lymphoma In The Brentuximab Vedotin Era

Paolo Anderlini - European Group for Blood and Marrow Transplantation (EBMT) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Hodgkin's Lymphoma

Adcetris

Phase 1 Study of Carfilzomib in Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

Attaphol Pawarode - European Group for Blood and Marrow Transplantation (EBMT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Hematological malignancies

carfilzomib Intravenous

CAN WE PREDICT TIME TO TUMOR PROGRESSION IN EARLY COLORECTAL CANCER PATIENTS USING CTCS COUNT?

Michela Roberto - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

COMPARISON OF KRAS MUTATION STATUS BETWEEN PRIMARY TUMORS AND CIRCULATING TUMOR CELLS IN PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC)

Aristea Kalikaki - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

THE DETECTION OF CIRCULATING TUMOR CELLS IN COLORECTAL CANCER USING QPCR AND ITS EFFECT ON ANALGESIA

Josef Srovnal - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

A COMPARISON OF THE MAIN COST-EFFECTIVENESS DRIVERS OF VIRTUAL COLONOGRAPHY VERSUS CONVENTIONAL COLONOSCOPY FOR COLORECTAL CANCER SCREENING: AN INTERNATIONAL REVIEW

Christine Kriza - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

Filters

1671 Abstracts